文献速递外周动脉疾病

下肢外周血管介入中栓塞保护装置的使用与结局

The Use of Embolic Protection Devices during Lower Extremity Peripheral Vascular Interventions.
PubMed 文献 · Ann Vasc Surg · 2020-06-15

基于VSGNE数据库2010–2014年10875例下肢外周血管介入(PVI),EPD使用率仅2%但逐年从1.1%升至3.5%。倾向匹配后182例EPD与604例对照在技术成功、通畅率、截肢和死亡上无差异,EPD与透视时间增加相关。

要点

  • EPD在下肢PVI中使用率低(2%)但2010–2014年显著增加(1.1%→3.5%,P<0.001)。
  • 倾向匹配后EPD与无EPD组在远端栓塞、技术成功、通畅率、截肢和死亡上无显著差异。
  • EPD使用与透视时间增加显著相关(平均比1.2,95%CI 1.1–1.3)。

核心结论

  • EPD在下肢PVI中并未改善结局,却增加操作复杂性和透视时间。

研究设计与样本

  • 回顾性队列研究,基于血管研究组新英格兰(VSGNE)数据库2010–2014年共10875例下肢PVI。
  • 倾向匹配后比较182例EPD与604例无EPD对照,并进行多变量分析。

主要发现

  • EPD使用率从2010年1.1%升至2014年3.5%(P<0.001)。
  • 匹配后两组 minor 远端栓塞(1.1% vs. 1.5%)及需腔内治疗的远端栓塞(2.8% vs. 2.6%)无显著差异。
  • EPD组更常用切除性斑块旋切(26.4% vs. 12.6%),无EPD组更常用轨道斑块旋切(31.9% vs. 41.6%,P=0.017)。
  • 多变量分析示EPD与通畅率(IRR 1.1,95%CI 0.9–1.3)、截肢(IRR 0.7,95%CI 0.2–2.1)、死亡(IRR 0.8,95%CI 0.6–1.2)无显著关联。
  • EPD与透视时间显著增加相关(平均比1.2,95%CI 1.1–1.3)。

临床怎么用

  • 不应常规使用EPD,需权衡其增加的透视时间与操作复杂度。
  • 应进一步研究确定哪些患者可能从EPD中获益。

局限性

  • EPD使用率仅2%,匹配后样本量有限(182例 vs. 604例)。
  • 回顾性数据库研究,可能存在选择偏倚和未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of embolic protection device (EPD) during lower extremity peripheral vascular interventions (PVI) has been reported, but its impact on outcomes is unclear. The goal of this study was to assess the use and outcomes of EPDs during PVI. METHODS: All PVI between 2010 and 2014 in the Vascular Study Group of New England (VSGNE) database were reviewed. The characteristics of patients and lesions treated with EPD were identified. A propensity-matched control group without EPD was selected. The outcomes of both groups were compared, and a multivariable analysis was performed. RESULTS: There were a total of 10,875 procedures. EPD was used in 2% of the procedures. From 2010 to 2014, EPD use significantly increased from 1.1 to 3.5% (P < 0.001). Patients undergoing PVI with EPD were less likely to be white but more likely to have diabetes, chronic obstructive pulmonary disease, coronary artery disease, and history of prior PVI. After propensity matching, there were 182 procedures with EPD and 604 controls with no significant difference in risk factors. There was no difference in indication or anatomic level treated, with claudication (52.7% vs. 49.8%) being most common indication and the superficial femoral artery (65.4% vs. 62.1%), the most commonly treated artery. Patients undergoing PVI with EPD were more likely to be treated with excisional atherectomy (26.4% vs. 12.6%), whereas patients without EPD were more likely to be treated with orbital atherectomy (31.9% vs. 41.6%, P = 0.017). There was no significant difference in the incidence of minor distal embolization (DE) (1.1% vs. 1.5%) or DE requiring endovascular treatment (2.8% vs. 2.6%) between the two groups, but EPD use was significantly associated with increased fluoroscopy time (P < 0.001). There was no difference in technical success, patency, amputation, or mortality between the two groups. On multivariable analysis, there was no significant association between the use of EPD and patency (incidence relative risk (IRR) [95% CI] = 1.1 [0.9-1.3]), amputation (IRR = 0.7 [0.2-2.1]), or mortality (IRR = 0.8 [0.6-1.2]). However, there was a significant difference in fluoroscopy time (mean ratio [95% CI] = 1.2 [1.1-1.3]). The analysis was repeated after eliminating all procedures with DE in the EPD group (assuming that EPD use is 100% effective in preventing DE), and the results were no different. CONCLUSIONS: EPD use during PVI has significantly increased. Despite EPDs increasing procedural complexity and time, they do not seem to have any impact on PVI outcomes. Additional studies are needed to characterize which patients would benefit from EPDs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ochoa Chaar CI, Kim TI, Shebl FM, et al. The Use of Embolic Protection Devices during Lower Extremity Peripheral Vascular Interventions. Ann Vasc Surg. 2020. PMID: 32554197. doi:10.1016/j.avsg.2020.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。